Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vitacro-L
- Development stage
- Unknown
- Lead developer
- Croise Pharma
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Vitacro-L is an oral nutritional supplement developed and marketed by Croise Pharma. Formulated as a tablet or softgel capsule, it contains a combination of lycopene, astaxanthin, ginseng, multivitamins, and multiminerals. It is designed to provide antioxidant support, promote overall health, and prevent or treat vitamin and mineral deficiencies. The active ingredients work synergistically to neutralize free radicals, support metabolic processes, and maintain immune function.
- Brand names
- VITACRO-LVitacro L
- Other names
- astaxanthin + ginseng + lycopene + multiminerals + multivitaminslycopene + multivitamins + multiminerals
Beyond the preview
Go deeper on Vitacro-L.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vitacro-L.